Global Nasal Spray Market Growth to surge with Increasing Adoption due to Easy Administration Methods

Inkwood Research estimates that the Global Nasal Spray Market is evaluated to register a CAGR of 9.39% in terms of revenue during the forecasting years of 2021-2028.

"Browse 65 Market Data Tables and 54 Figures spread over 230 Pages, along with an in-depth TOC on the Global Nasal Spray Market Forecast 2021-2028."

REQUEST FREE SAMPLE LINK - https://inkwoodresearch.com/reports/nasal-spray-market/#request-free-sample?utm_source=paidpr&utm_medium=inkwood&utm_campaign=openpr

Nasal sprays are liquid medicines sprayed into the nose. They are of different types and help in tackling allergies. They are available either as prescriptions or over the counter. They come in two forms, pump and regular.

Rising Adoption of Nasal Sprays drives Market Growth

Intranasal administration minimizes the possibility of systemic adverse effects and medication interactions. Medication is administered directly through a nasal spray to the site of allergic irritation. Also, a nasal spray is considered a gentle, non-invasive, and promising alternative. The nasal mucosa is very immunocompetent due to its regular exposure to microorganisms and dust. Moreover, intranasal vaccination offers wider protection, given the presence of nasal-associated lymphoid tissue (NALT).

Furthermore, intranasal administration induces systemic immunity and mucosal (protection at the site of infection). This includes the activation of circulating immune cells and antibody formation. Also, the nasal route offers cross-protection against virus strains like influenza. In addition, nasal sprays are cost-effective and easy-to-use solutions, and hence, are being increasingly preferred by patients worldwide.

Major Product: Decongestion Nasal Spray

A decongestion nasal spray offers temporary relief from nasal congestion caused due to allergies, hay fever, sinusitis, and the common cold. Also, it shrinks swollen tissues and blood vessels that cause congestion. Phenylephrine hydrochloride (Neo-Synephrine) and oxymetazoline hydrochloride (Afrin, Dristan, Sinex) are examples of decongestion nasal sprays.

Highest Revenue Share: North America

North America is witnessing increasing cases of allergic rhinitis and infections. Also, the trends like painless drug administration, growing pollution rates, increasing geriatric population, rising patient compliance, and changing lifestyles are the additional key drivers of market growth in the region. Moreover, nasal spray adoption as an efficient drug administration route, coupled with the rising demand for self-administration, offers ample market growth opportunities.

The strong competitive space is created by companies with larger product portfolios and undifferentiated products. Also, these companies are investing heavily in R&D and expanding their facilities. Pfizer Inc, Johnson & Johnson, Proctor & Gamble Co, Sun Pharmaceuticals Industries Ltd, GlaxoSmithKline Plc, etc., are among the major firms in the market.

VIEW TABLE OF CONTENT LINK - https://inkwoodresearch.com/reports/nasal-spray-market/#table-of-contents?utm_source=paidpr&utm_medium=inkwood&utm_campaign=openpr

About Inkwood Research
Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy, with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.

Contact Us
https://inkwoodresearch.com
sales@inkwoodresearch.com
+1 857-302-4704

This release was published on openPR.